Harshman, L.C.;
Logue, J.;
Sternberg, C.N.;
Sundar, S.;
Schrijvers, D.;
Schostak, M.;
Sylvester, J.;
George, S.;
Tucci, M.;
Mantz, C.;
Borrega, P.;
Ziem, P.;
Concepcion, R.;
Miller, K.;
Sartor, O.;
Kalinovsky, J.;
De Sanctis, Y.;
Tombal, B.
First interim results of the radium-223 (Ra-223) REASSURE observational study: Analysis of patient (Pt) characteristics and safety by use of abiraterone and/or enzalutamide (Abi/Enza)
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
First interim results of the radium-223 (Ra-223) REASSURE observational study: Analysis of patient (Pt) characteristics and safety by use of abiraterone and/or enzalutamide (Abi/Enza)
Contributor:
Harshman, L.C.;
Logue, J.;
Sternberg, C.N.;
Sundar, S.;
Schrijvers, D.;
Schostak, M.;
Sylvester, J.;
George, S.;
Tucci, M.;
Mantz, C.;
Borrega, P.;
Ziem, P.;
Concepcion, R.;
Miller, K.;
Sartor, O.;
Kalinovsky, J.;
De Sanctis, Y.;
Tombal, B.